✦ LIBER ✦

Identification of reproducible ventricular tachycardia in a canine model

✍ Scribed by Gust H. Bardy; William M. Smith; Ross M. Ungerleider; James L. Cox; John J. Gallagher; Raymond E. Ideker

Book ID: 115671097
Publisher: Elsevier Science
Year: 1984
Tongue: English
Weight: 816 KB
Volume: 53
Category: Article
ISSN: 0002-9149
DOI: 10.1016/0002-9149(84)90041-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Novel Stable Reproducible Model of Hep

A Novel Stable Reproducible Model of Hepatic Failure in Canines

✍ Samir S. Awad; Mark R. Hemmila; Oliver S. Soldes; Shigeki Sawada; Preston B. Ric 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 258 KB

A Novel Canine Model of Spinal Cord Isch

A Novel Canine Model of Spinal Cord Ischemia with Reproducible Neurologic Outcomes

✍ Yuji Sugawara; Hajime Kumagai; Taijiro Sueda 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 291 KB

Identification of risk of ventricular ta

Identification of risk of ventricular tachycardia in patients with hypertrophic cardiomyopathy

✍ S. Trzos; W.J. Musial; W. Kozlowski; M. Kurpesa 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Epicardial mapping of polymorphous ventr

Epicardial mapping of polymorphous ventricular tachycardias induced in the canine heart with procainamide

✍ Yuji Murakawa; Hiroshi Inoue; Iku Toda; Akira Nozaki; Kiyoshi Kawakubo; Tsuneaki 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 696 KB

Acute induction of sustained ventricular

Acute induction of sustained ventricular tachycardia: A new porcine model

✍ C. Schmid; J. Nitsch; B. Lüderitz 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 531 KB

Effect of SC-40230, a new class I antiar

Effect of SC-40230, a new class I antiarrhythmic agent, on canine ventricular tachycardias

✍ S. Garthwaite; Frida Hatley; Leo Frederick; Jeanette Ruby; Chyung Cook 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 975 KB

SC-40230, a-[2-[acetyl( 1 -methylethyl) amino]ethyl]-tr-(2-chlorophenyl)-l -piperidinebutanamide, a new class I antiarrhythmic agent, was tested for efficacy against coronary ligation-induced arrhythmias and ouabain toxicity arrhythmias in dogs. Doses of 9 mg/kg i.v. and 15, 25, and 35 mgikg p.0. s